Envestnet Asset Management Inc Adma Biologics, Inc. Transaction History
Envestnet Asset Management Inc
- $326 Billion
- Q2 2025
A detailed history of Envestnet Asset Management Inc transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 143,229 shares of ADMA stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
143,229
Previous 68,686
108.53%
Holding current value
$2.14 Million
Previous $1.36 Million
91.48%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ADMA
# of Institutions
401Shares Held
196MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$320 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$279 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$192 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$181 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$88.5 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.94B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...